Cite

HARVARD Citation

    Ou, Y. et al. (2017). Population Pharmacokinetics and Exposure–Response Relationship of Carfilzomib in Patients With Multiple Myeloma. Journal of clinical pharmacology. pp. 663-677. [Online]. 
  
Back to record